首页> 美国卫生研究院文献>International Journal of Epidemiology >Power and sample size estimation for epigenome-wide association scans to detect differential DNA methylation
【2h】

Power and sample size estimation for epigenome-wide association scans to detect differential DNA methylation

机译:用于表观基因组范围的关联扫描以检测差异DNA甲基化的功效和样本大小估计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Epigenome-wide association scans (EWAS) are under way for many complex human traits, but EWAS power has not been fully assessed. We investigate power of EWAS to detect differential methylation using case-control and disease-discordant monozygotic (MZ) twin designs with genome-wide DNA methylation arrays.>Methods and Results: We performed simulations to estimate power under the case-control and discordant MZ twin EWAS study designs, under a range of epigenetic risk effect sizes and conditions. For example, to detect a 10% mean methylation difference between affected and unaffected subjects at a genome-wide significance threshold of P = 1 × 10−6, 98 MZ twin pairs were required to reach 80% EWAS power, and 112 cases and 112 controls pairs were needed in the case-control design. We also estimated the minimum sample size required to reach 80% EWAS power under both study designs. Our analyses highlighted several factors that significantly influenced EWAS power, including sample size, epigenetic risk effect size, the variance of DNA methylation at the locus of interest and the correlation in DNA methylation patterns within the twin sample.>Conclusions: We provide power estimates for array-based DNA methylation EWAS under case-control and disease-discordant MZ twin designs, and explore multiple factors that impact on EWAS power. Our results can help guide EWAS experimental design and interpretation for future epigenetic studies.
机译:>背景:目前正在针对许多复杂的人类特征进行表观基因组范围的关联扫描(EWAS),但尚未完全评估EWAS的功能。我们使用全基因组DNA甲基化阵列的病例对照和疾病不一致单卵(MZ)孪生设计研究EWAS检测差异甲基化的能力。>方法和结果:我们进行了仿真,以估计在病例对照和不一致的MZ双EWAS研究设计在一系列表观遗传风险影响大小和条件下进行。例如,要在全基因组显着性阈值为P = 1×10 -6 时检测受影响和未受影响受试者之间10%的平均甲基化差异,需要98 requiredMZ双胞胎对才能达到80%EWAS电源,案例控制设计中需要112个案例和112个控件对。我们还估计了两种研究设计下达到80%EWAS功效所需的最小样本量。我们的分析强调了几个显着影响EWAS能力的因素,包括样本量,表观遗传风险效应大小,目标基因位点DNA甲基化的变异以及双胞胎样本中DNA甲基化模式的相关性。>结论:我们为病例控制和疾病不一致的MZ双胞胎设计提供了基于阵列的DNA甲基化EWAS的功率估计,并探讨了影响EWAS功率的多个因素。我们的结果可以帮助指导EWAS实验设计和对未来表观遗传学研究的解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号